World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon
Novavax at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Novavax takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions cover next-generation vaccine technology and its own protein-based approach. The most concrete looks at the potential of the Novavax technology platform, including its Matrix-M adjuvant.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Novavax Gaithersburg, MD | |
Vaccine company developing protein-based vaccines with its Matrix-M adjuvant, including a marketed COVID-19 vaccine. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 14:00 |
Find decision makers at Novavax
Tell us what you sell and we’ll find the people at Novavax most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction